These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 27655073)

  • 1. Ellagitannins, Gallotannins and their Metabolites- The Contribution to the Anti-Inflammatory Effect of Food Products and Medicinal Plants.
    Kiss AK; Piwowarski JP
    Curr Med Chem; 2018; 25(37):4946-4967. PubMed ID: 27655073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials.
    Piwowarski JP; Granica S; Zwierzyńska M; Stefańska J; Schopohl P; Melzig MF; Kiss AK
    J Ethnopharmacol; 2014 Aug; 155(1):801-9. PubMed ID: 24969824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages.
    Piwowarski JP; Kiss AK; Granica S; Moeslinger T
    Mol Nutr Food Res; 2015 Nov; 59(11):2168-77. PubMed ID: 26202092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of gut microbiota-derived ellagitannins' metabolites urolithins on pro-inflammatory activities of human neutrophils.
    Piwowarski JP; Granica S; Kiss AK
    Planta Med; 2014 Jul; 80(11):887-95. PubMed ID: 24995502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Metabolism of Ellagitannins by Human Gut Microbiota ex Vivo Cultures.
    Piwowarski JP; Granica S; Stefańska J; Kiss AK
    J Nat Prod; 2016 Dec; 79(12):3022-3030. PubMed ID: 28006907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Bioaccessibility, Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: A Case of Padma Hepaten® Formulation.
    Olennikov DN; Kashchenko NI; Chirikova NK
    Nutrients; 2015 Oct; 7(10):8456-77. PubMed ID: 26473917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urolithins, the rescue of "old" metabolites to understand a "new" concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status.
    Tomás-Barberán FA; González-Sarrías A; García-Villalba R; Núñez-Sánchez MA; Selma MV; García-Conesa MT; Espín JC
    Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27158799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies of urolithins and their phase II metabolites on macrophage and neutrophil functions.
    Bobowska A; Granica S; Filipek A; Melzig MF; Moeslinger T; Zentek J; Kruk A; Piwowarski JP
    Eur J Nutr; 2021 Jun; 60(4):1957-1972. PubMed ID: 32960290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scope of Hydrolysable Tannins as Possible Antimicrobial Agent.
    Ekambaram SP; Perumal SS; Balakrishnan A
    Phytother Res; 2016 Jul; 30(7):1035-45. PubMed ID: 27062587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ellagitannins modulate the inflammatory response of human neutrophils ex vivo.
    Granica S; Piwowarski JP; Kiss AK
    Phytomedicine; 2015 Dec; 22(14):1215-22. PubMed ID: 26655403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A commentary on methodological aspects of hydrolysable tannins metabolism in ruminant: a perspective view.
    Lotfi R
    Lett Appl Microbiol; 2020 Nov; 71(5):466-478. PubMed ID: 32654165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strawberry processing does not affect the production and urinary excretion of urolithins, ellagic acid metabolites, in humans.
    Truchado P; Larrosa M; García-Conesa MT; Cerdá B; Vidal-Guevara ML; Tomás-Barberán FA; Espín JC
    J Agric Food Chem; 2012 Jun; 60(23):5749-54. PubMed ID: 22126674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ellagitannins, ellagic acid and vascular health.
    Larrosa M; García-Conesa MT; Espín JC; Tomás-Barberán FA
    Mol Aspects Med; 2010 Dec; 31(6):513-39. PubMed ID: 20837052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure, occurrence and biological activity of ellagitannins: a general review.
    Lipińska L; Klewicka E; Sójka M
    Acta Sci Pol Technol Aliment; 2014; 13(3):289-99. PubMed ID: 24887944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota Modulation and Anti-Inflammatory Properties of Dietary Polyphenols in IBD: New and Consolidated Perspectives.
    Santino A; Scarano A; De Santis S; De Benedictis M; Giovinazzo G; Chieppa M
    Curr Pharm Des; 2017; 23(16):2344-2351. PubMed ID: 28176667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic fate of ellagitannins: implications for health, and research perspectives for innovative functional foods.
    Garcia-Muñoz C; Vaillant F
    Crit Rev Food Sci Nutr; 2014; 54(12):1584-98. PubMed ID: 24580560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ellagitannin-rich berries on blood lipids, gut microbiota, and urolithin production in human subjects with symptoms of metabolic syndrome.
    Puupponen-Pimiä R; Seppänen-Laakso T; Kankainen M; Maukonen J; Törrönen R; Kolehmainen M; Leppänen T; Moilanen E; Nohynek L; Aura AM; Poutanen K; Tómas-Barberán FA; Espín JC; Oksman-Caldentey KM
    Mol Nutr Food Res; 2013 Dec; 57(12):2258-63. PubMed ID: 23934737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal stability of urolithins: an in vitro approach.
    Mena P; Dall'Asta M; Calani L; Brighenti F; Del Rio D
    Eur J Nutr; 2017 Feb; 56(1):99-106. PubMed ID: 26439723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ellagitannins, urolithins, and neuroprotection: Human evidence and the possible link to the gut microbiota.
    García-Villalba R; Tomás-Barberán FA; Iglesias-Aguirre CE; Giménez-Bastida JA; González-Sarrías A; Selma MV; Espín JC
    Mol Aspects Med; 2023 Feb; 89():101109. PubMed ID: 35940941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of gut microbiota for the activity of medicinal plants traditionally used in the European Union for gastrointestinal disorders.
    Thumann TA; Pferschy-Wenzig EM; Moissl-Eichinger C; Bauer R
    J Ethnopharmacol; 2019 Dec; 245():112153. PubMed ID: 31408679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.